UCSF

ZINC03920355

Draw Identity 99% 90% 80% 70%

Substance Information

In ZINC since Heavy atoms Benign functionality
October 19th, 2005 39 No

Popular Name: Fosinopril Fosinopril

Find On: PubMed — Wikipedia — Google

CAS Numbers: 88889-14-9 , 98048-97-6

Other Names:

(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid; (2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid; F

(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

(2S,4S)-4-cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid

(2S,4S)-4-cyclohexyl-1-{2-[2-methyl-1-(propanoyloxy)propoxy(4-phenylbutyl)phosphoryl]acetyl}pyrrolidine-2-carboxylic acid

(4S)-4-Cyclohexyl-1-(((R)-((S)-1-hydroxy-2-methylpropoxy)(4-phenylbutyl)phosphinyl)acetyl-L-proline propionate (ester), sodium salt; Acenor-M; C30H45NNaO7P; Dynacil; Eliten; FOSINOPRIL SODIUM; Fosinil; Fosinopril sodium [USAN]; Fosinorm; Fosipres; Fositen

(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-prolinate

(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-proline

(4S)-4-cyclohexyl-1-{[{[2-methyl-1-(propanoyloxy)propyl]oxy}(4-phenylbutyl)phosphoryl]acetyl}-L-proline

pril

4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

88889-14-9; D00622; Fosinopril sodium (USAN); Monopril (TN)

98048-97-6

98048-97-6; C07016; Fosinopril

98048-97-6; D07992; Fosinopril (INN); Monopril (TN)

AC-13899

AC1L1FW8

AC1L1K09

AC1O8F9P

Acecor

BIDD:GT0229

C07016

C30H46NO7P

C30H46NO7P; Fosenopril; Fosinopril; Fosinopril [INN:BAN]; Fosinopril sodium; Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer; L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (1(S*(R*)),2alpha,4beta)-; L-Prol

CHEBI:159901; CHEBI:288733

CID10461195

CID3420

CID55891

CID6708482

CID9601226

CID9872634

D07992

DAP000582

DB00492

DivK1c_000908

FDA

fos-

Fosenopril

Fosinopril (BAN

Fosinopril (INN)

Fosinopril Sodium

Fosinopril [INN:BAN]

fosinopril(1-)

Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer

HMS2089P08

IDI1_000908

INN); Fosinopril Sodium (FDA

KBio1_000908

KBioGR_001544

L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (1(S*(R*)),2alpha,4beta)-

L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (2alpha,4beta)-

L-proline,4-cyclohexyl-1-(((2-methyl-1-Z(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-(1(S*(R*)),2alpha,4beta)-

LS-118919

LS-187220

MFCD00897699

MolPort-005-934-570

Monopril

Monopril (TN)

NINDS_000908

Spectrum4_001102

SQ-28,555

SQ-28555

Staril

UNII-R43D2573WO

USAN)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.59 3.1 -66.23 0 8 -1 113 562.664 15 ↓

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.01e-03 g/l DrugBank-approved
Indications antihypertensive KeyOrganics Bioactives
PUBCHEM_PATENT_ID EP0755265A1; EP0755446A1; EP0827408A1; EP0830143A1; EP1014859A1; EP1025216A1; US5362899; US5420328; US5565428; US5571675; US5571893; US5573762; US5610134; US5624806; US5627073; US5661122; US5668134; US5723585; US5741776; US5767155; US5837241; US5968981; U IBM Patent Data

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )